Free Trial

AquaBounty Technologies Q2 2023 Earnings Report

AquaBounty Technologies logo
$0.52 -0.01 (-1.21%)
(As of 12/20/2024 05:40 PM ET)

AquaBounty Technologies EPS Results

Actual EPS
-$1.80
Consensus EPS
-$1.60
Beat/Miss
Missed by -$0.20
One Year Ago EPS
N/A

AquaBounty Technologies Revenue Results

Actual Revenue
$0.79 million
Expected Revenue
$0.45 million
Beat/Miss
Beat by +$340.00 thousand
YoY Revenue Growth
N/A

AquaBounty Technologies Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment (Ad)

This isn't just another investment. It might be the last retirement stock you'll ever need. But this window of opportunity is closing fast.

Click here for the ticker >>>
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like AquaBounty Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on AquaBounty Technologies and other key companies, straight to your email.

About AquaBounty Technologies

AquaBounty Technologies (NASDAQ:AQB), a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.

View AquaBounty Technologies Profile

More Earnings Resources from MarketBeat

Upcoming Earnings